Adagene (ADAG) Non-Current Debt (2019 - 2025)

Adagene's (ADAG) quarterly Non-Current Debt came in at $1138.2 billion in Q4 2025, up 172.72% year-on-year from $417.3 billion in Q4 2024, and up 172.72% on a QoQ basis from $417.3 billion in Q4 2024.

Adagene (ADAG) Non-Current Debt (2019 - 2025) Analysis & Trends

Adagene (ADAG) has 7 years of Non-Current Debt data on file, last reported at $1138.2 billion in Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 172.72% year-over-year to $1138.2 billion in Q4 2025; TTM through Dec 2025 was $1138.2 billion, a 172.72% increase from a year earlier, with the FY2025 full-year figure at $1138.2 billion, up 172.72% from the prior year.
  • Non-Current Debt for Q4 2025 stood at $1138.2 billion, up from $417.3 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for ADAG reached as high as $14146.5 billion in Q4 2022 and fell as low as $2.0 million in Q2 2021.
  • Historically, Non-Current Debt has averaged $5761.2 billion across 5 years, with a median of $1138.2 billion in 2025.
  • Across the five-year window, Non-Current Debt soared 472839123.1% in 2022 and plunged 100.0% in 2024, its largest moves.
  • Year by year, Non-Current Debt stood at $3.0 million in 2021, then surged by 472839123.1% to $14146.5 billion in 2022, then fell by 4.29% to $13540.0 billion in 2023, then slumped by 96.92% to $417.3 billion in 2024, then soared by 172.72% to $1138.2 billion in 2025.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $1138.2 billion in Q4 2025, $417.3 billion in Q4 2024, and $4.6 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 105.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 842.92 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Adagene 198.85 Mn 198.85 Mn - 1,138.17 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1,138.17 Bn
Dec 31, 2024 417.34 Bn
Jun 30, 2024 4.56 Mn
Dec 31, 2023 13,540.03 Bn
Jun 30, 2023 13,348.00 Bn
Dec 31, 2022 14,146.54 Bn
Jun 30, 2022 9,260.36 Bn
Dec 31, 2021 2.99 Mn
Jun 30, 2021 2.00 Mn
Dec 31, 2020 2.97 Mn
Dec 31, 2019 1.52 Mn